ALPS ADVISORS INC CRISPR Therapeutics AG Transaction History

ALPS ADVISORS INC portfolio value:

$2.78M
portfolio value

ALPS ADVISORS INC quarter portfolio value change:

+7.54%
quarter

CRISPR Therapeutics AG 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -7.33% -3.36K shares -9K $65.35 42.58K
Q2 2022 share Increase 0.00% 45.95K shares 2.79M $60.77 45.95K
Q2 2019 share Decrease -100.00% -125.11K shares -4.46M $47.1 0
Q1 2019 share Increase +5.33% 6.32K shares 1.07M $35.72 125.11K
Q4 2018 share Increase 0.00% 118.79K shares 3.39M $28.57 118.79K